LT2994479T - Modifikuota prolil-4-hidroksilazės ekspresija physcomitrella patens - Google Patents

Modifikuota prolil-4-hidroksilazės ekspresija physcomitrella patens

Info

Publication number
LT2994479T
LT2994479T LT14720988T LT14720988T LT2994479T LT 2994479 T LT2994479 T LT 2994479T LT 14720988 T LT14720988 T LT 14720988T LT 14720988 T LT14720988 T LT 14720988T LT 2994479 T LT2994479 T LT 2994479T
Authority
LT
Lithuania
Prior art keywords
physcoitrella
patens
prolyl
hydroxylase
modified expression
Prior art date
Application number
LT14720988T
Other languages
English (en)
Inventor
Ralf Reski
Juliana Parsons
Friedrich Altmann
Manuela Graf
Eva Decker
Johannes Stadlmann
Original Assignee
Univ Freiburg Albert Ludwigs
Univ Wien Bodenkultur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg Albert Ludwigs, Univ Wien Bodenkultur filed Critical Univ Freiburg Albert Ludwigs
Publication of LT2994479T publication Critical patent/LT2994479T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C12Y114/11002—Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
LT14720988T 2013-05-06 2014-05-05 Modifikuota prolil-4-hidroksilazės ekspresija physcomitrella patens LT2994479T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1308120.3A GB201308120D0 (en) 2013-05-06 2013-05-06 Recombinant protein and method for its production
PCT/EP2014/059132 WO2014180793A1 (en) 2013-05-06 2014-05-05 Modified expression of prolyl-4-hydroxylase in physcoitrella patens

Publications (1)

Publication Number Publication Date
LT2994479T true LT2994479T (lt) 2019-10-25

Family

ID=48627341

Family Applications (1)

Application Number Title Priority Date Filing Date
LT14720988T LT2994479T (lt) 2013-05-06 2014-05-05 Modifikuota prolil-4-hidroksilazės ekspresija physcomitrella patens

Country Status (16)

Country Link
US (1) US10174334B2 (lt)
EP (1) EP2994479B1 (lt)
JP (1) JP6588892B2 (lt)
KR (1) KR101906442B1 (lt)
AU (1) AU2014264732B2 (lt)
BR (1) BR112015027982A2 (lt)
CA (1) CA2911083C (lt)
DK (1) DK2994479T3 (lt)
ES (1) ES2744993T3 (lt)
GB (1) GB201308120D0 (lt)
HR (1) HRP20191556T1 (lt)
LT (1) LT2994479T (lt)
PL (1) PL2994479T3 (lt)
PT (1) PT2994479T (lt)
SI (1) SI2994479T1 (lt)
WO (1) WO2014180793A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3162540A1 (en) * 2020-02-14 2021-08-19 Lixin Dai Monomeric proteins for hydroxylating amino acids and products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001029242A2 (en) * 1999-10-21 2001-04-26 Monsanto Company Post-translational modification of recombinant proteins produced in plants
KR100389141B1 (ko) 2000-05-18 2003-06-25 동아제약 주식회사 인간 에리스로포이에틴을 고효율로 발현하는 재조합세포주 및 이의 제조방법
EP3088528B1 (en) * 2004-09-29 2019-07-03 Collplant Ltd. Collagen producing plants and methods of generating and using same
PT1904636E (pt) * 2005-07-12 2010-09-14 Greenovation Biotech Gmbh Melhoramentos na ou relacionados com a produção de proteínas

Also Published As

Publication number Publication date
ES2744993T3 (es) 2020-02-27
BR112015027982A2 (pt) 2017-10-17
AU2014264732A1 (en) 2015-12-03
AU2014264732B2 (en) 2017-04-13
WO2014180793A1 (en) 2014-11-13
DK2994479T3 (da) 2019-09-23
SI2994479T1 (sl) 2019-12-31
CA2911083A1 (en) 2014-11-13
PL2994479T3 (pl) 2020-02-28
JP6588892B2 (ja) 2019-10-09
US20160208275A1 (en) 2016-07-21
CA2911083C (en) 2020-09-15
JP2016519136A (ja) 2016-06-30
KR20150143593A (ko) 2015-12-23
EP2994479A1 (en) 2016-03-16
EP2994479B1 (en) 2019-06-19
US10174334B2 (en) 2019-01-08
KR101906442B1 (ko) 2018-12-07
HRP20191556T1 (hr) 2019-11-29
GB201308120D0 (en) 2013-06-12
PT2994479T (pt) 2019-09-30

Similar Documents

Publication Publication Date Title
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
HK1219975A1 (zh) 用於病毒生產的細胞系和使用方法
HK1221224A1 (zh) 依洛昔巴特的結晶修飾物
HK1213818A1 (zh) 依帕列淨的治療用途
HK1218512A1 (zh) 雜環化合物和其用途
HUE060721T2 (hu) Empagliflozin terápiás alkalmazásai
HRP20181710T1 (hr) Uporaba derivata benzimidazol-prolina
HK1220363A1 (zh) 雜環化合物及其用途
EP3632467C0 (en) INHIBITORS OF COMPLEMENT FACTOR H
PL2994479T3 (pl) Zmodyfikowana ekspresja prolilo-4-hydroksylazy w physcoitrella patens
AU5220P (en) Jewel of DesertTopaz Delosperma cooperi
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling
GB201304608D0 (en) BenTime of Yisrael operable arrangement
GB201304140D0 (en) Improvements relating to hinges